5-Aminosalicylic Acid

규격

89-57-6CAS 번호

201-919-1EC 번호

5-amino-2-hydroxybenzoic acidIUPAC 명칭

C7H7NO3화학식

153.14 g/mol분자량

5-Aminosalicylic acid; mesalamine; Mesalazine; 89-57-6; 5-Amino-2-hydroxybenzoic acid; 5-ASA; Fisalamine; Lialda; m-Aminosalicylic acid; Benzoic acid, 5-amino-2-hydroxy-; Apriso; Mesalazina; sfRowasa; Asacolitin; Mesalazinum; Iialda; p-Aminosalicylsaeure; Asacol HD; Pentacol; 3-carboxy-4-hydroxyaniline; Delzicol; Mezavant XL; MAX-002; SALICYLIC ACID, 5-AMINO-; NSC-38877; DTXSID5024506; 4Q81I59GXC; CHEBI:6775; 5 Aminosalicylate; DTXCID804506; 4-14-00-02058 (Beilstein Handbook Reference); NSC38877; Ipocol; m Aminosalicylic Acid; 5 Aminosalicylic Acid; Novo 5 ASA; meta Aminosalicylic Acid; meta-Aminosalicylic Acid; Hydrochloride, Mesalamine; Monosodium Salt, Mesalamine; Octasa; Pentasa sr; Coltec ec; Mesren mr; Mesalamine Rectal; ZALDYON; RefChem:6004; A07EC02; sfRowasa Sulfite-Free Formulation; 201-919-1; Pentasa; Asacol; Canasa; Claversal; Salofalk; Rowasa; Mesasal; 5-amino-2-hydroxy-benzoic acid; Lixacol; 5-Amino Salicylic Acid; Mesalamine [USAN]; 2-Hydroxy-5-aminobenzoic acid; MFCD00007877; 5-AS; NSC 38877; Mesalazine [INN]; 5-?Aminosalicylic Acid (Mesalazine); MLS001424012; mesalamine (USAN); 51481-17-5; CAS-89-57-6; NCGC00016344-03; Mesalazinum [Latin]; SMR000145728; 5-amino-2-hydroxybenzoic acid,5-Aminosalicylic acid; F1918-0003; Mesalazina [Spanish]; p-Aminosalicylsaeure [German]; Mesavancol; Mesavance; Mezavant; Mesalazine MMX; Mesalamine (USP); Pentasa (TN); Salofalk Granu-Stix; Apriso (TN); Asacol (TN); Canasa (TN); Lialda (TN); Rowasa (TN); CCRIS 7334; 5-Amino 2-hydroxy benzoic acid; SR-01000763486; Mesalamine [USAN:USP]; EINECS 201-919-1; BRN 2090421; UNII-4Q81I59GXC; 5-amino-2-hydroxybenzoicacid; Mesalazin; 3-amino-6-hydroxybenzoic acid; Fisalamine;; Mesalamine;; Mesalazine;; AI3-15564; Claversal;; Pentasa;; Mesalazine CRS; Asacol;; Asalit;; Rowasa;; HSDB 7512; AJG-501; SPD 476; SPD-476; SPD-480; Mesalamine (TN); Delzicol (TN); Sfrowasa (TN); Mesalamine (Lialda); 5-aminosalicylic_acid; MD-0901; 5-Aminosalicyclic acid; 5-amino-salicylic acid; Mesalamine (5-ASA); 5-Aminosalicylic acid;; MESALAMINE [MI]; MESALAZINE [JAN]; Prestwick0_001069; Prestwick1_001069; Prestwick2_001069; Prestwick3_001069; MESALAMINE [HSDB]; WLN: ZR DQ CVQ; Z-206; MESALAMINE [VANDF]; CHEMBL704; Epitope ID:613406; Mesalazine (JP18/INN); EC 201-919-1; cid_4075; MESALAZINE [MART.]; MESALAMINE [USP-RS]; MESALAZINE [WHO-DD]; Oprea1_847633; SCHEMBL31297; 3amino-6-hydroxybenzoic acid; BSPBio_001058; KBioGR_002425; KBioSS_002431; MLS000758287; 5-Aminosalicylic acid, 95%; 5-Aminosalicylic acid, tablet; BIDD:GT0811; SCHEMBL343127; SPBio_002969; BPBio1_001164; GTPL2700; orb1310419; orb3139226; SCHEMBL7075986; MESALAMINE [ORANGE BOOK]; MESALAZINE [EP IMPURITY]; SCHEMBL29354798; 5-Aminosalicylic acid, >=99%; BDBM60918; KBio2_002425; KBio2_004993; KBio2_007561; KBio3_002904; 5-Aminosalicylic acid (5-ASA); MESALAZINE [EP MONOGRAPH]; 5-Aminosalicylic Acid (Standard); cMAP_000045; HMS1571E20; HMS2051M21; HMS2090I09; HMS2098E20; HMS3393M21; HMS3649K15; HMS3651M15; HMS3715E20; HMS5079B12; MESALAMINE [USP MONOGRAPH]; Pharmakon1600-01505993; SMSSF-0065812; Tox21_110384; Tox21_201610; Tox21_303125; AC8101; BBL013046; EBC-00537; HY-15027R; MSK159016; NSC759301; s1681; SBB052617; Sodium aminosalicylate EP Impurity B; STK301678; Mesalazine for system suitability CRS; AKOS000118959; Tox21_110384_1; AC-2764; CCG-100829; DB00244; FM25111; HS-0100; NC00079; NSC-759301; NCGC00016344-01; NCGC00016344-02; NCGC00016344-04; NCGC00016344-05; NCGC00016344-07; NCGC00090934-01; NCGC00090934-02; NCGC00257142-01; NCGC00259159-01; 5-amino-2-hydroxobenzoic acid monohydrate; BP-13074; DA-70181; HY-15027; SY002854; 5-Aminosalicylic acid, analytical standard; ST4109571; A0317; A2291; A5035; AB00374979; NS00004165; SW197303-4; T0646; EN300-18389; C07138; D00377; AB00374979-09; AB00374979-10; AB00374979_11; AB00374979_12; F065629; Q412479; SR-01000763486-3; SR-01000763486-4; SR-01000763486-9; BRD-K28849549-001-11-8; BRD-K28849549-001-12-6; BRD-K28849549-001-13-4; Z57127471; Mesalazine Working Standard (Secondary Reference Standard); Mesalazine, European Pharmacopoeia (EP) Reference Standard; Mesalamine, United States Pharmacopeia (USP) Reference Standard; Mesalamine, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11; Mesalazine for system suitability, European Pharmacopoeia (EP) Reference Standard; OO3; Mesalamin동의어